SCDM Archives - Clinical ink Wed, 12 Mar 2025 15:55:00 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.2 https://www.clinicalink.com/wp-content/uploads/2022/03/cropped-Clinical-Ink-Icon-Logo-32x32.png SCDM Archives - Clinical ink 32 32 Clinical ink Reveals Disruptive Technologies’ Worth in Clinical Research https://www.clinicalink.com/disruptive-technologies-in-clinical-research/ Mon, 20 Jun 2022 12:29:00 +0000 https://www.clinicalink.com/?p=9839 Will Present WATCH-PD Case Study at SCDM 2022 EMEA Conference Horsham, PA, June 20th, 2022 – David Anderson, PhD, Senior Scientist at Clinical ink, will […]

The post Clinical ink Reveals Disruptive Technologies’ Worth in Clinical Research appeared first on Clinical ink.

]]>
Will Present WATCH-PD Case Study at SCDM 2022 EMEA Conference

Horsham, PA, June 20th, 2022 – David Anderson, PhD, Senior Scientist at Clinical ink, will be presenting insights from our experience designing, deploying, and analyzing the WATCH-PD study in the talk “Disruptive Technologies Simplified: Real World Case Studies.” The session will be held in Basel, Switzerland at the Society for Clinical Data Management (SCDM) 2022 EMEA Leadership Forum & Conference on Thursday, June 23rd from 3:45-5:00 pm CEST (Brussels) or 9:45-11 am ET (America). 

Anderson, who holds a Ph.D. in Neurological Sciences, has over a decade of experience developing hardware and software capabilities to evaluate mechanisms of visual perception, attention, and working memory. He will speak to how the advanced technology team at Clinical ink integrated data from multiple sensors and assessments, implemented high-dimensional feature engineering pipelines, and evaluated scalable machine learning algorithms to develop digital biomarkers for Parkinson’s in the remotely monitored portion of the WATCH-PD study. 

Learn more about the work Clinical ink has done in Parkinson’s, and the WATCH-PD study.  

About Clinical Ink

Clinical ink is the global life science company that brings data, technology, and patient science together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience

About the Society for Clinical Data Management (SCDM) 

Established in 1994, the Society for Clinical Data Management (SCDM) is a non-profit, international organization of over 2,800 members founded to advance the discipline of clinical data management.

SCDM members are charged with promoting quality and excellence in data management and are dedicated to the development, support and advancement of clinical data management professionals. SCDM is organized exclusively for educational purposes and seeks to engage with relevant organizations that can support to advance its mission, to “Connect and inspire professionals managing global health data with global education, certification and advocacy.” Learn more about SCDM.

The post Clinical ink Reveals Disruptive Technologies’ Worth in Clinical Research appeared first on Clinical ink.

]]>
Clinical Ink’s COO & Chief Data Officer, Jonathan Andrus, Awarded SCDM Lifetime Achievement Award https://www.clinicalink.com/ccochiefdataofficer/ Tue, 16 Apr 2019 09:35:15 +0000 https://www.clinicalink.com/uncategorized/ccochiefdataofficer/ Clinical Ink is excited to recognize its COO & Chief Data Officer, Jonathan Andrus, for being awarded the SCDM Lifetime Achievement Award at the September […]

The post Clinical Ink’s COO & Chief Data Officer, Jonathan Andrus, Awarded SCDM Lifetime Achievement Award appeared first on Clinical ink.

]]>
Clinical Ink is excited to recognize its COO & Chief Data Officer, Jonathan Andrus, for being awarded the SCDM Lifetime Achievement Award at the September 2018 SCDM Annual Conference. The Society for Clinical Data Management (SCDM) honored Jonathan for his contributions over the past twenty years, including his past role as SCDM Chair, and present roles as Treasurer and Member of the Board of Trustees. The society is recognized as the world’s largest clinical data management professional organization.Jonathan has been deeply involved with the SCDM organization since 1998. He ran for and was elected to the Board in 2004 and has served in a variety of capacities over the past 14 years, including as Vice Chair, Chair and Treasurer. Most recently, he was appointed for another three-year term, stating, “I’m looking forward to the continued growth and expansion of the society, which will ensure the continued education and advancement of the data management profession.”

Passionate about data management, Jonathan has helped grow the professional society on a global scale, including playing a major role in moving its headquarters from the US to Europe. Further, he has been instrumental in working with the society’s European, Indian, Chinese and Japanese members, supporting and growing activities in these regions with the aim of globally advancing data management.

At Clinical Ink, Jonathan focuses his initiatives on providing customers with the most compliant, efficient and quality-oriented products and services, stating, “Customer satisfaction is my number one priority and our entire company is united under the mission of providing our customers with the best possible experience by delivering a modern approach to clinical trial execution and data management.”

Congratulations to Jonathan for this tremendous recognition. Clinical Ink and the clinical trial data management industry are appreciative of your contributions to advancing clinical trial execution.

About Clinical Ink

Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. Founded in 2007, the Company’s proven and future-built CAPTURE platform, which includes solutions for EDC replacement, eCOA, ePRO and more, accelerates time to value while delivering scientific results that matter. With offices in Winston-Salem, NC, and Philadelphia, PA, Clinical Ink is advancing the business model responsible for bringing new treatments to market. Visit clinicalink.com.

Media Contact: Jessica Romero | 336.728.6541 | jessica.romero@clinicalink.com

The post Clinical Ink’s COO & Chief Data Officer, Jonathan Andrus, Awarded SCDM Lifetime Achievement Award appeared first on Clinical ink.

]]>